Innovation

Research and development collaboration between Nencki Institute and Pikralida Sp. z o. o., to treat epileptogenesis

13.07.2021

Nencki Institute and Pikralida Sp. z o. o. collaborate on „Use of matrix metalloproteinase inhibitor to develop an innovative therapy of preventing the development of post-traumatic and post-stroke epilepsy” project, which is cofunded by the European Funds. The aim of the project is to develop an innovative therapeutic method for preventing post-traumatic and post-stroke epileptic seizures by modulating matrix metalloproteinase 9 (MMP-9) activity. Tasks include i.a. development of the ...

Collaboration Agreement between Nencki Institute and Thereson S.r.l.

09.07.2021

Nencki Institute PAS has entered a research collaboration with Thereson, a company focusing on therapeutic magnetic resonance. Laboratory of Mitochondrial Biology and Metabolism, led by ...

Master Agreement between Nencki Institute and ALAB bioscience

08.03.2021

We are pleased to announce that Nencki Institute PAS has established the cooperation with ALAB Bioscience laboratory. We will support ALAB Bioscience in the field of flow cytometry and electron ...

Patent Granted in USA for the Nencki Institute

02.12.2020

The United States Patent and Trademark Office has issued a decision to grant a patent for the invention entitled: "PRION PROTEIN-DENDRIMER CONJUGATES FOR USE IN TREATMENT OF ALZHEIMER DISEASE" ...

Patent granted in USA for the invention from Nencki Institute and Center for Theoretical Physics PAS

04.08.2020

United States Patent and Trademark Office granted a patent for the invention entiled "An ecologically relevant system and a method for testing spontaneous social interactions in group-housed ...